Outset Medical, Inc. - Common Stock, par value of $0.001 per share (OM)
CUSIP: 690145206
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock, par value of $0.001 per share
- Shares outstanding
- 18,116,200
- Total 13F shares
- 15,349,498
- Share change
- -2,751,140
- Total reported value
- $56,943,759
- Price per share
- $3.71
- Number of holders
- 93
- Value change
- -$38,452,775
- Number of buys
- 49
- Number of sells
- 46
Quarterly Holders Quick Answers
What is CUSIP 690145206?
CUSIP 690145206 identifies OM - Outset Medical, Inc. - Common Stock, par value of $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 690145206:
Top shareholders of OM - Outset Medical, Inc. - Common Stock, par value of $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
13D/G
|
Company |
14%
from 13D/G
|
2,664,798
|
$37,626,948 | — | 30 Sep 2025 | |
| PFM Health Sciences, LP |
13F
13D/G
|
Company |
2.9%
from 13D/G
|
1,729,921
|
$24,426,485 | — | 30 Sep 2025 | |
| Alyeska Investment Group, L.P. |
13F
13D/G
|
Company |
9.6%
from 13D/G
|
1,614,582
|
$22,797,898 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13D/G
13F
|
The Vanguard Group · Company |
5.6%
|
991,429
|
$18,919,737 | $0 | 30 Jun 2025 | |
| Woodline Partners LP |
13F
13D/G
|
Company |
7.5%
from 13D/G
|
1,325,855
|
$18,721,073 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
6.8%
from 13D/G
|
1,248,956
|
$17,635,259 | — | 30 Sep 2025 | |
| Durable Capital Partners LP |
13F
|
Company |
5.7%
|
1,023,706
|
$14,454,729 | — | 30 Sep 2025 | |
| PERCEPTIVE ADVISORS LLC |
13D/G
13F
|
Company |
6.7%
|
1,208,334
|
$14,028,758 | $0 | 31 Mar 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
3.5%
|
631,663
|
$8,919,082 | — | 30 Sep 2025 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
2.5%
|
454,512
|
$6,417,709 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
2.4%
|
433,175
|
$6,116,432 | — | 30 Sep 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.3%
|
421,409
|
$5,950,295 | — | 30 Sep 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
2.3%
|
419,118
|
$5,917,945 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
397,259
|
$5,610,651 | — | 30 Sep 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
2.1%
|
377,033
|
$5,323,706 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13D/G
13F
|
Company |
5.2%
|
950,558
|
$4,866,857 | $0 | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.8%
|
331,736
|
$4,684,112 | — | 30 Sep 2025 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
1.8%
|
326,087
|
$4,604,348 | — | 30 Sep 2025 | |
| Hackett Patrick T. |
3/4/5
|
Director |
1.2%
|
220,171
|
$3,368,614 | — | 02 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.3%
|
236,736
|
$3,342,712 | — | 30 Sep 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.81%
|
146,598
|
$2,069,964 | — | 30 Sep 2025 | |
| Renee Gaeta |
3/4/5
|
Chief Financial Officer |
0.73%
|
131,425
|
$2,010,802 | — | 10 Jun 2025 | |
| Catalio Capital Management, LP |
13F
|
Company |
0.65%
|
118,279
|
$1,670,099 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.64%
|
116,306
|
$1,642,241 | — | 30 Sep 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.64%
|
116,291
|
$1,642,029 | — | 30 Sep 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.63%
|
114,800
|
$1,620,973 | — | 30 Sep 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.57%
|
103,766
|
$1,465,176 | — | 30 Sep 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.55%
|
99,963
|
$1,409,000 | — | 30 Sep 2025 | |
| GMT CAPITAL CORP |
13F
|
Company |
0.54%
|
98,108
|
$1,385,285 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.53%
|
96,084
|
$1,356,706 | — | 30 Sep 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.52%
|
94,966
|
$1,340,920 | — | 30 Sep 2025 | |
| Steven S. Williamson |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
320,347
|
$1,143,639 | — | 15 Feb 2024 | |
| Birchview Capital, LP |
13F
|
Company |
0.43%
|
78,584
|
$1,109,606 | — | 30 Sep 2025 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.4%
|
72,931
|
$1,030,000 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.4%
|
72,441
|
$1,022,868 | — | 30 Sep 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.4%
|
72,117
|
$1,018,292 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.39%
|
71,330
|
$1,007,180 | — | 30 Sep 2025 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.03%
|
5,000
|
$1,000,167 | — | 30 Sep 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.38%
|
68,941
|
$973,447 | — | 30 Sep 2025 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
0.37%
|
66,666
|
$941,000 | — | 30 Sep 2025 | |
| Jean-Olivier Racine |
3/4/5
|
Chief Technology Officer |
—
class O/S missing
|
265,325
|
$867,613 | — | 10 May 2024 | |
| Susquehanna Portfolio Strategies, LLC |
13F
|
Company |
0.33%
|
58,972
|
$832,685 | — | 30 Sep 2025 | |
| Y-Intercept (Hong Kong) Ltd |
13F
|
Company |
0.3%
|
54,005
|
$762,551 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.29%
|
52,311
|
$738,631 | — | 30 Sep 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.29%
|
51,822
|
$731,726 | — | 30 Sep 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.25%
|
44,869
|
$633,550 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.23%
|
42,033
|
$593,506 | — | 30 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.22%
|
40,460
|
$571,295 | — | 30 Sep 2025 | |
| Brent D. Lang |
3/4/5
|
Director |
0.19%
|
34,517
|
$528,109 | — | 02 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.19%
|
34,676
|
$489,625 | — | 30 Sep 2025 |
Institutional Holders of Outset Medical, Inc. - Common Stock, par value of $0.001 per share (OM) as of Q4 2025
As of 31 Dec 2025,
Outset Medical, Inc. - Common Stock, par value of $0.001 per share (OM) was held by
93 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,349,498 shares.
The largest 10 holders included
FMR LLC, Alyeska Investment Group, L.P., Woodline Partners LP, BlackRock, Inc., VANGUARD GROUP INC, BANK OF AMERICA CORP /DE/, PERCEPTIVE ADVISORS LLC, Ensign Peak Advisors, Inc, BML Capital Management, LLC, and PFM Health Sciences, LP.
This page lists
93
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
96
Q4 2025 holders
93
Holder diff
-3
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.